228 PUBLICATIONS AND CONFERENCE PRESENTATIONS • NHG-wetenschapsdag, Amsterdam, 8 June 2018 • Oral presentation: De FRAIL-AF studie: Het switchen van VKA naar NOAC bij kwetsbare ouderen met atriumfibrilleren. [Dutch] • Symposium Kenniscentrum Trombosezorg Saltro, Utrecht, 2 November 2017 • Oral presentation: FRAIL-AF onderzoek: Optimale anticoagulantia bij kwetsbare ouderen. [Dutch] • Jaarcongres HartVaatHAG, Utrecht, 29 September 2017 • Pitch and poster: De FRAIL-AF studie: Het switchen van VKA naar NOAC bij kwetsbare ouderen met atriumfibrilleren. [Dutch] • Connect-AF, Arnhem, 28 March 2017 • Oral presentation: FRAIL-AF studie: Switchen van anticoagulantiatherapie bij kwetsbare ouderen met atriumfibrilleren. [Dutch] INTERNATIONAL CONFERENCE PRESENTATIONS • ESC 2023, Amsterdam, 25-28 August 2023 • Oral presentation at a hot line session, ESC TV, ask the trialist, 6 video interviews: Safety of switching from a vitamin K antagonist to a non-vitamin K antagonist oral anticoagulant in frail older patients with atrial fibrillation: Results of the FRAIL-AF randomized controlled trial. • ISTH 2022, London, 9-13 July 2022 • Poster: Sex- and age specific association of new-onset atrial fibrillation with in-hospital mortality in hospitalised COVID-19 patients. • Poster: Atrial fibrillation: trends in prevalence and antithrombotic prescriptions in primary care. • ISTH 2019, Melbourne, 6-10 July 2019 • Poster: Design of the FRAIL-AF Trial: Safety of Switching from VKA to DOAC in Frail Elderly with Atrial Fibrillation. • Poster: Off-label Dose Reduction of Direct Oral Anticoagulants in Atrial Fibrillation: A Systematic Review and Meta-analysis. • WONCA, Kraków, 24-27 May 2018 • Oral presentation: Design of the FRAIL-AF study: Safety of switching anticoagulant management (from VKA to DOAC) in frail elderly patients with atrial fibrillation: a randomised controlled trial. • Workshop: Thrombosis in primary care: Diagnostics, Prognostics and Treatment. • Europrevent, Ljubljana, 19-21 April 2018 • Poster: FRAIL-AF study: Switching from VKA to NOAC in frail elderly patients with atrial fibrillation.
RkJQdWJsaXNoZXIy MTk4NDMw